Big Move For Heat Biologics, Inc.
Fri, Feb 28, 2020 at 05:30 PM
Heat Biologics, Inc. (HTBX:NASDAQ) jumped higher at $0.33, representing a gain of 54.9%. On Thu 27 Feb 20, HTBX:NASDAQ touched a New 2-Week Low of $0.21. The stock got featured on our News Catalysts scanner on Tue 25 Feb 20 at 04:15 AM in the 'MISCELLANEOUS' category. From Thu 06 Feb 20, the stock recorded 21.43% Up Days and 13.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Heat Biologics, Inc. (HTBX:NASDAQ)
Heat Biologics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of novel allogeneic, 'off-the-shelf' cellular therapeutic vaccines to combat various cancers and infectious diseases.
Top 10 Gainers:
- iBio, Inc. (IBIO:NYSEMKT), 183.24%
- Biocept, Inc. (BIOC:NASDAQ), 168.87%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 143.21%
- Altimmune, Inc. (ALT:NASDAQ), 110.23%
- OpGen, Inc. (OPGN:NASDAQ), 66.18%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 62.9%
- Dynatronics Corporation (DYNT:NASDAQ), 59.34%
- Heat Biologics, Inc. (HTBX:NASDAQ), 54.93%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 54.64%
- Correvio Pharma Corp. (CORV:NASDAQ), 50.82%